Robert C. Stoler

Featured in: Favicon

jamanetwork.com Favicon

healio.com Favicon

onlinelibrary.wiley.com

Articles

Ultrathin bioresorbable polymer sirolimus‐eluting stents in US patients undergoing coronary revascularization: 1‐Year outcomes from the BIOFLOW VII trial - Kandzari - Catheterization and Cardiovascular Interventions - Wiley Online Library

Jul 26, 2023 | onlinelibrary.wiley.com | David Kandzari |Hector M. Garcia-Garcia |Robert C. Stoler |Baylor Scott

Abstract Background Ultrathin strut coronary drug-eluting stents (DES) have demonstrated improved safety and efficacy in large contemporary trials. The evaluation of an ultrathin strut DES in a post-market United States (US) patient population was undertaken.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →